Active Ingredient(s): Sulfur Hexafluoride Lipid-type A Microspheres
FDA Approved: * October 10, 2014
Pharm Company: * BRACCO
Category: Diagnostic Aid

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Lumason Overview

Esaflon Sulfur(VI) fluoride Sulfuric fluoride Identifiers CAS Number 2551-62-4Y 3D model (JSmol) Interactive image ChEBI CHEBI:30496Y ChemSpider 16425Y ECHA InfoCard 100.018.050 EC Number 219-854-2 Gmelin Reference 2752 KEGG D05962N MeSH Sulfur+hexafluoride PubChem CID 17358 RTECS number WS4900000 UNII WS7LR3I1D6N UN number 1080 CompTox Dashboard (EPA) DTXSID8029656 InChI InChI=1S/F6S/c1-7(2,3,4,5)6YKey:SFZCNBIFKDRMGX-UHFFFAOYSA-NY ...

Read more Lumason Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Lumason Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Sulfur Hexafluoride Lipid-type A Microspheres
  • For Suspension: 60.7mg/25mg
  • Suspension: 60.7mg + 25mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Lumason: (3 results)

Sorted by National Drug Code
  • 0270-7097 Lumason Intravenous; Intravesical Injection, Powder, Lyophilized, for Suspension by Bracco Diagnostics Inc
  • 0270-7099 Lumason Kit by Bracco Diagnostics Inc
  • 68155-099 LumasonLumason Kit by Bracco Suisse Sa

Other drugs which contain Sulfur Hexafluoride Lipid-type A Microspheres or a similar ingredient: (1 result)